Advertisement
Despite increasing rates of use

Echo Underused During Critical Cardiovascular Hospitalizations

0
Findings of underuse despite steady growth in use from 2001 to 2011

January 2016 Briefing – Cardiology

0
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for January 2016. This roundup includes the latest...
Some clinical departments tend to undertreat when prescribing statins

Many Physicians Show Tendency to Undertreat With Statins

0
Target levels more likely to be achieved in departments that prescribe more statins
Reduction in albuminuria with the renin inhibitor aliskiren may be too small to confer clinical benefit in patients with type 2 diabetes

No Benefit From Aliskiren-Tied Drops in Albuminuria

0
Overall albuminuria drop may be too small for cardiovascular, renal risk protection
Mobile telephone text messaging may be a promising new way to improve adherence to medications for chronic diseases

Mobile Texts May Up Adherence to Meds for Chronic Illness

0
Meta-analysis shows mobile phone text reminders double the odds of medication adherence
Lipid-lowering therapy with ezetimibe plus simvastatin is associated with improved clinical outcomes

Ezetimibe/Simvastatin Ups Clinical Outcomes in IMPROVE-IT

0
Reduction in total primary end point events, driven by reductions in myocardial infarction, stroke
Demand for medical office space for ambulatory care is at a high point and looks likely to continue increasing

Demand for Medical Office Space High and Increasing

0
Vacancy rate for medical office buildings 9.5 percent in third quarter of 2015; lowest since 2007
For patients hospitalized with acute myocardial infarction (AMI)

n-3 PUFA Tx After AMI Linked to Drop in Death, Recurrent AMI

0
Treatment linked to reduction in all-cause mortality, recurrent acute MI though 12-month follow-up
For warfarin-treated patients

Carbamazepine Affects Warfarin Anticoagulation

0
Carbamazepine co-treatment linked to subtherapeutic anticoagulative effect of warfarin
The top four issues that will be promoted in state legislation in 2016 were discussed at the 2016 American Medical Association (AMA) State Legislative Strategy Conference

AMA Highlights Top Four Issues to Promote in State Legislation

0
Issues include physician-led team-based care, improving patient health, reducing rx drug overdose